+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Mexico Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update

  • PDF Icon

    Report

  • 51 Pages
  • August 2023
  • Region: Mexico
  • BioIntel360
  • ID: 5774433
UP TO OFF until Dec 31st 2024
According to the publisher, Mexico biosimilar market size is expected to record a CAGR of 13.3% during 2023-2027 to reach US$1.348 billion by 2027, increasing from US$0.749 billion in 2023. Over the last five years, the sector has recorded a CAGR of 15.3% to reach US$0.650 billion in 2022.

This report provides an in-depth data-centric analysis of the emerging opportunities in the biosimilars industry. It covers a detailed view of market size and forecast across various segments such as by product, type of cell, imaging technique, procedure, source of manufacturing, applications, type of technology, and end users.

This section is a part of the title “Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, and Competitive Landscape - Q2 2023 Update”.

Scope

This report provides an in-depth, data-centric analysis of the Mexico biosimilar market 2018-2027. Below is a summary of key market segments:

Biosimilar Market Size By Product

  • Monoclonal Antibody Biosimilars
  • Insulin Biosimilar
  • Biosimilar Interferons
  • Other Biosimilar

Biosimilar Market Size By Type of Cell

  • Mammalian
  • Non-Mammalian

Biosimilar Market Size By Imaging Technique

  • Magnetic Resonance Imaging Scanners
  • Computed Tomography Scanners
  • Positron Emission Tomography Scanners
  • Others

Biosimilar Market Size By Procedure

  • Invasive
  • Non-Invasive

Biosimilar Market Size By Source of Manufacturing

  • In-House
  • Contract Manufacturing

Biosimilar Market Size By Applications

  • Oncology
  • Blood Disorders
  • Growth Hormonal Deficiency
  • Chronic & Autoimmune Disorders
  • Infectious Diseases
  • Others

Biosimilar Market Size By Type of Technology

  • Mass Spectroscopy
  • Chromatography
  • Recombinant DNA technology
  • Electrophoresis
  • Others

Biosimilar Market Size By End User

  • Hospital & Clinics
  • Diagnostic Centres
  • Others

Reasons to buy

  • In-depth understanding of biosimilars market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Mexico.
  • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
  • Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals & clinics, diagnostic centres within the Mexico.

Table of Contents

1 Mexico Biosimilar Market Size and Forecast, 2018-2027
2 Mexico Biosimilar Market Share by Product, 2018-2027
2.1 Biosimilar Market Size by Monoclonal Antibody Biosimilars, 2018-2027
2.2 Biosimilar Market Size by Insulin Biosimilar, 2018-2027
2.3 Biosimilar Market Size by Biosimilar Interferons, 2018-2027
2.4 Biosimilar Market Size by Other Biosimilars, 2018-2027
3 Mexico Biosimilar Market Share by Monoclonal Antibody Biosimilars, 2018-20274 Mexico Biosimilar Market Share by Insulin Biosimilars, 2018-20275 Mexico Biosimilar Market Share by Interferons Biosimilars, 2018-20276 Mexico Biosimilar Market Share by Other Biosimilars, 2018-2027
7 Mexico Biosimilar Market Share by Type of Cell, 2018-2027
7.1 Biosimilar Market Size by Mammalian Cell, 2018-2027
7.2 Biosimilar Market Size by Non-Mammalian Cell, 2018-2027
8 Mexico Biosimilar Market Share by Imaging Technique, 2018-2027
8.1 Biosimilar Market Size by Magnetic Resonance Imaging Scanners, 2018-2027
8.2 Biosimilar Market Size by Computed Tomography Scanners, 2018-2027
8.3 Biosimilar Market Size by Positron Emission Tomography Scanners, 2018-2027
8.4 Biosimilar Market Size by Others, 2018-2027
9 Mexico Biosimilar Market Share by Procedure, 2018-2027
9.1 Biosimilar Market Size by Invasive Procedure, 2018-2027
9.2 Biosimilar Market Size by Non-Invasive Procedure, 2018-2027
10 Mexico Biosimilar Market Share by Source of Manufacturing, 2018-2027
10.1 Biosimilar Market Size by In-House, 2018-2027
10.2 Biosimilar Market Size by Contract Manufacturing, 2018-2027
11 Mexico Biosimilar Market Share by Applications, 2018-2027
11.1 Biosimilar Market Size by Oncology, 2018-2027
11.2 Biosimilar Market Size by Blood Disorders, 2018-2027
11.3 Biosimilar Market Size by Growth Hormonal Deficiency, 2018-2027
11.4 Biosimilar Market Size by Chronic & Autoimmune Disorders, 2018-2027
11.5 Biosimilar Market Size by Infectious Diseases, 2018-2027
11.6 Biosimilar Market Size by Others, 2018-2027
12 Mexico Biosimilar Market Share by Type of Technology, 2018-2027
12.1 Biosimilar Market Size by Mass Spectroscopy, 2018-2027
12.2 Biosimilar Market Size by Chromatography, 2018-2027
12.3 Biosimilar Market Size by Recombinant DNA Technology, 2018-2027
12.4 Biosimilar Market Size by Electrophoresis, 2018-2027
12.5 Biosimilar Market Size by Others, 2018-2027
13 Mexico Biosimilar Market Share by End User, 2018-2027
13.1 Biosimilar Market Size by Hospital & Clinics, 2018-2027
13.2 Biosimilar Market Size by Diagnostic Centres, 2018-2027
13.3 Biosimilar Market Size by Others, 2018-2027

Methodology

Loading
LOADING...

Table Information